Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Pharmacogenomics|July 30, 2020
CYP2C19 genotype-guided antiplatelet therapy: promises and pitfallsMoataz Ellithi, Jordan Baye, Russell A WilkeJournal of the American Pharmacists Association : Japha|August 15, 2025
Evaluation of the Impact of CYP2D6 Testing on Outcomes in Patients Taking OpioidsHalle Brady, Max Weaver, Jordan Baye, et al.Pharmacotherapy|March 27, 2013
Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasiaMatthew A Cantrell, Jordan Baye, Scott Martin VouriPharmacogenomics|May 1, 2023
Patient satisfaction with return of pharmacogenomic results utilizing a patient portal messageJoel Van Heukelom, Kristen Jacobsen, Natasha J Petry, et al.Pharmacogenomics|March 21, 2025
Impact of a pharmacogenomics (PGx) clinic on patient satisfaction and PGx literacyAmanda Massmann, Jordan Baye, Max Weaver, et al.South Dakota Medicine : the Journal of the South Dakota State Medical Association|March 9, 2023
Cytochrome P450 2D6 Genotyping for Post-Operative OpioidsJacob Thomsen, Russell A Wilke, Matthew Jahraus, et al.Clinical Pharmacology and Therapeutics|January 16, 2022
SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine CareDeepak Voora, Jordan Baye, Adam McDermaid, et al.Pharmacogenomics|August 28, 2019
Implementation of wide-scale pharmacogenetic testing in primary careNatasha Petry, Jordan Baye, Aissa Aifaoui, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 9, 2025
Pharmacogenomics case-based education: Establishment of an Extension for Community Health Outcomes (ECHO) education model for healthcare professionalsPamala A Jacobson, Alyssa N K Johnson, Jeffrey R Bishop, et al.Pageof 1